Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
02/12/2004 | US20040026804 Generation of nanoparticles and microparticles of controllable size using acoustic and ultrasonic vibration |
02/12/2004 | DE10235270A1 Zellen, die R-alpha-Liponsäure sekretieren und Verfahren zur fermentativen Herstellung der R-alpha-Liponsäure Cells that secrete R-alpha-lipoic acid and process for the fermentative production of the R-alpha-lipoic acid |
02/12/2004 | DE10233676A1 New polypeptide allergens from fungi, useful in desensitizing vaccines and for diagnosis, also related nucleic acids, vectors and transformed cells |
02/12/2004 | DE10232621A1 Für ein Enzym Delta-12-Desaturase kodierende Nukleinsäuresequenz, zugehöriges Polypeptid und Verwendung von beiden For an enzyme delta-12 desaturase-encoding nucleic acid sequence associated polypeptide and use of both |
02/12/2004 | CA2495478A1 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
02/12/2004 | CA2495123A1 Methods of identifying compounds that modulate protein activity |
02/12/2004 | CA2494837A1 Novel druggable regions in set domain proteins and methods of using the same |
02/12/2004 | CA2494607A1 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
02/12/2004 | CA2494268A1 Recombinant biotin carboxylase domains for identification of acetyl coa carboxylase inhibitors |
02/12/2004 | CA2493935A1 Method for the biotransformation of carotenoids by means of a cytochrome p450 monooxygenase |
02/12/2004 | CA2493364A1 Inversion of the negative-selective effect of negative marker proteins using selection methods |
02/12/2004 | CA2492966A1 Method for the expression of unknown environmental dna into adapted host cells |
02/12/2004 | CA2492945A1 Tocopherol biosynthesis related genes and uses thereof |
02/12/2004 | CA2492750A1 Use of lactobacillus to produce exopolysaccharides in food and pharmaceutical compositions |
02/11/2004 | EP1387893A1 An assay for detecting inhibitors of the enzyme mueloperokidase |
02/11/2004 | EP1387891A2 Compounds and methods for inhibiting axillary malodour |
02/11/2004 | EP1387890A2 Peptidylarginine deiminase 6 |
02/11/2004 | EP1387889A2 Kinases and phosphatases |
02/11/2004 | EP1387886A2 Proteases |
02/11/2004 | EP1387616A2 Method of preparing a dough with an enzyme |
02/11/2004 | EP0936912B1 Inhibitors of cysteine protease |
02/11/2004 | CN1474873A Thermotolerant ribonuclease H |
02/11/2004 | CN1474872A Method for modifying plant morphology, biochemistry and physiology |
02/11/2004 | CN1474871A Inhibitor proteins |
02/11/2004 | CN1474682A Enzymatic coloring agents |
02/11/2004 | CN1473931A Novel fermented soya beans streptokinase, its producing method and microbe for producing said streptokinase |
02/11/2004 | CN1138146C Method for detecting existence of anti-tissue transglutaminase antibody in body liquid externally |
02/11/2004 | CN1138002C Method for activation of blood coagulation factor XII |
02/11/2004 | CN1137995C Method for creating plant gene label system |
02/11/2004 | CN1137994C Polypeptide having glucanotransferase activity and nucleic acids encoding same |
02/10/2004 | US6689939 GTP binding stress-related proteins and methods of use in plants |
02/10/2004 | US6689880 DNA molecule for detecting glyphosate tolerant wheat plant 33391 and progeny thereof |
02/10/2004 | US6689874 Gene for enzyme having both alkaline pullulanase and alkaline alpha-amylase activities |
02/10/2004 | US6689610 Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same |
02/10/2004 | US6689604 Lipopolysaccharide α-2,3 sialyltransferase of Campylobacter jejuni and its uses |
02/10/2004 | US6689601 High growth methanotropic bacterial strain |
02/10/2004 | US6689599 Aggrecanase molecules |
02/10/2004 | US6689598 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
02/10/2004 | US6689597 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
02/10/2004 | US6689596 High level expression of human cyclooxygenase-2 |
02/10/2004 | US6689595 Crystallization and structure determination of Staphylococcus aureus thymidylate kinase |
02/10/2004 | US6689593 Generation of farnesol; culture genetically engineered microorganism in nutrient broth, ferment in nutrient broth and recover farnesol |
02/10/2004 | US6689589 Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids |
02/10/2004 | US6689588 Use in column containing the immobilized alliinase and collecting pure allicin in effluent; pure allicin has as food additive or pharmaceutical for infections, thrombosis or hyperlipidemia |
02/10/2004 | US6689587 Polynucleotides encoding the nadC gene and methods of producing nicotinic acid or nicotinic acid derivatives |
02/10/2004 | US6689578 Inhibition of 5-aminolevulinate synthase gene expression in fungi results in no signs of successful infection or lesions. 5-aminolevulinate synthase can be used as a target for the identification of antibiotics, preferably antifungals. |
02/10/2004 | US6689575 IκB kinase, subunits thereof, and methods of using same |
02/10/2004 | US6689573 Method for screening restriction endonucleases |
02/10/2004 | US6689567 Screening for an inhibitor of an enzyme with flaa1-like activity via a spectrophotometric assay using udp-glcnac as substrate; enzyme inhibitor against c6-dehydratase/c4-reductase useful as antibiotics for h. pylori for example |
02/10/2004 | US6689564 Transgenic animal; for use in the detection, prevention and treatment of skin disorders |
02/10/2004 | US6689557 Method of identifying a substance that affects long term memory and CREM/CREB/ATF-1 subfamily members |
02/10/2004 | US6689358 Phytase variants |
02/10/2004 | US6689357 Non-obligate predatory bacterium Burkholderia casidae and uses thereof |
02/10/2004 | CA2123430C Prohormone convertase transformed cells |
02/05/2004 | WO2004011671A2 Diacylglycerol acyltransferase nucleic acid sequences and associated products |
02/05/2004 | WO2004011670A2 Methods and compositions for nad(p)(h) oxidases |
02/05/2004 | WO2004011667A2 Geranyl diphosphate synthase molecules, and nucleic acid molecules encoding same |
02/05/2004 | WO2004011657A1 Method for enhancing the nutritive value of plant extract |
02/05/2004 | WO2004011656A1 Method for enhancing yield of recombinant protein production from plants |
02/05/2004 | WO2004011654A1 Novel serine protease |
02/05/2004 | WO2004011653A1 Novel peptide synthase gene |
02/05/2004 | WO2004011652A1 Process for producing tripeptide or higher peptide |
02/05/2004 | WO2004011651A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
02/05/2004 | WO2004011648A2 CYTOCHROME P450s |
02/05/2004 | WO2004011641A2 Crystal structure of beta-site app-cleaving enzyme (bace) mutants and uses thereof |
02/05/2004 | WO2004011640A1 Three-dimensional structure of dipeptidyl peptidase iv |
02/05/2004 | WO2004011638A2 Deoxyuridine 5' triphosphate nucleotidohydrolase polypeptides and structures |
02/05/2004 | WO2004011637A2 Modified adamts4 molecules and method of use thereof |
02/05/2004 | WO2004011636A2 Method of enzymatic deubiquitination |
02/05/2004 | WO2004011635A1 Genes from propionibacterium freudenreichii encoding enzymes involved in vitamin b12 biosynthesis |
02/05/2004 | WO2004011628A1 New mutant strains of pseudomonas fluorescens and variants thereof, methods for their production, and uses thereof in alginate production |
02/05/2004 | WO2004011619A2 Thermostable protease with altered cleavage specificity |
02/05/2004 | WO2004011618A2 Methods of identifying adipocyte specific genes, the genes identified, and their uses |
02/05/2004 | WO2004011609A2 Methods for producing biological substances in pigment-deficient mutants of bacillus cells |
02/05/2004 | WO2004011605A2 Hybrid protein methods and compositions |
02/05/2004 | WO2004011491A2 Peptidyl-trna hydrolase of enterococcus faecalis |
02/05/2004 | WO2004011482A2 Clostripain activation process |
02/05/2004 | WO2004011424A2 Side chain anchored thioester and selenoester generators |
02/05/2004 | WO2004011025A1 Plant cell wall loosening activity of group 2/3 allergens of grass pollen |
02/05/2004 | WO2004010927A2 Method for increasing insulin sensitivity and for treating and preventing type 2 diabetes |
02/05/2004 | WO2003097789A3 Farnesyl diphosphate synthase from pseudomonas aeruginosa |
02/05/2004 | WO2003092607A3 Crystal structure of aurora-2 protein and binding pockets thereof |
02/05/2004 | WO2003087353A3 Purified polypeptides involved in membrane biogenesis |
02/05/2004 | WO2003087352A3 Enolase polypeptides and structures |
02/05/2004 | WO2003083038A3 Disruption of the redk gene |
02/05/2004 | WO2003077853A3 Immortal porcine cells |
02/05/2004 | WO2003076629A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
02/05/2004 | WO2003057204A3 Modulation of iamt (pimt or pcmt) in immune system |
02/05/2004 | WO2003054139B1 Compositions and methods utilizing dna polymerases |
02/05/2004 | WO2003031605A3 Human gtpase involved in chronic obstructive pulmonary disease (copd) |
02/05/2004 | WO2003025196A3 Dsp-18 dual-specificity phosphatase |
02/05/2004 | WO2003024386A3 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis |
02/05/2004 | WO2003020947A3 Mid 9002, a human sulfatase family member and uses therefor |
02/05/2004 | WO2003005809A9 Method of elevating glutamic acid content in plant and plants having elevated glutamic acid content |
02/05/2004 | US20040025204 Plants and plant products |
02/05/2004 | US20040025203 Plant uridine diphosphate-glucose dehydrogenase genes, proteins, and uses thereof |
02/05/2004 | US20040025196 Comprises nucleotide sequences coding proteins with plenty of SH3 domains (POSH) for preventing viral and bacterial infection and replication; rational drug design; viricides; antiapoptosis agents; bactericides |
02/05/2004 | US20040024344 Rapid process for purfication and concentration of plasmin |
02/05/2004 | US20040024191 Multimerized DBH enhancer domains |
02/05/2004 | US20040024068 Antimicrobial compounds |